AR023873A1 - Formulacion - Google Patents

Formulacion

Info

Publication number
AR023873A1
AR023873A1 ARP000102193A ARP000102193A AR023873A1 AR 023873 A1 AR023873 A1 AR 023873A1 AR P000102193 A ARP000102193 A AR P000102193A AR P000102193 A ARP000102193 A AR P000102193A AR 023873 A1 AR023873 A1 AR 023873A1
Authority
AR
Argentina
Prior art keywords
formulation
edisilate
clomethiazole
methylthiazole
edisylate
Prior art date
Application number
ARP000102193A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR023873A1 publication Critical patent/AR023873A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulacion parenteral de edisilato de 5-(2-cloroetil)-4-metiltiazol (genéricamente conocido como edisilato de clometiazol) que tiene propiedadesantimicrobianas mejoradas además de estabilidad física, química y microbiologica como así también compatibilidad biologica.
ARP000102193A 1999-05-06 2000-05-05 Formulacion AR023873A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901658A SE9901658D0 (sv) 1999-05-06 1999-05-06 New formulation

Publications (1)

Publication Number Publication Date
AR023873A1 true AR023873A1 (es) 2002-09-04

Family

ID=20415507

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102193A AR023873A1 (es) 1999-05-06 2000-05-05 Formulacion

Country Status (7)

Country Link
EP (1) EP1178798A1 (es)
JP (1) JP2002544164A (es)
AR (1) AR023873A1 (es)
AU (1) AU4792200A (es)
SE (1) SE9901658D0 (es)
TN (1) TNSN00094A1 (es)
WO (1) WO2000067753A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK733888A (da) * 1988-01-12 1989-07-13 Fujisawa Pharmaceutical Co Stabiliseringsmiddel
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
SE8900564D0 (sv) * 1989-02-17 1989-02-17 Astra Ab Novel medicinal use
SE9002659D0 (sv) * 1990-08-15 1990-08-15 Astra Ab New pharmaceutical formulations

Also Published As

Publication number Publication date
JP2002544164A (ja) 2002-12-24
SE9901658D0 (sv) 1999-05-06
EP1178798A1 (en) 2002-02-13
WO2000067753A1 (en) 2000-11-16
TNSN00094A1 (fr) 2002-05-30
AU4792200A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
UY37994A (es) Moléculas de adn correspondientes a evento transgénico mon88017 y métodos para su detección
HRP20070012A2 (en) Immunostimulatory oligonucleotide multimers
ATE330038T1 (de) Nukleinsäure-biosensor
AR052980A1 (es) Preparacion de dispersiones polimericas de etileno - acido acrilico neutralizadas y uso en medios de impresion para mejorar la adhesion de pigmento organico digital
ATE548391T1 (de) Gefangene bindungsproteine als biosensoren
CR8385A (es) Pirimidinas sustituidas con sulfoximina como inhibidores de cdk y/o vegf, su preparacion y sus usos como medicamento
CN103667141B (zh) 一种工业污水处理菌剂
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
WO2005040317A3 (en) Fuel substance and associated cartridge for fuel cell
WO2008092041A3 (en) Optical biosensors
WO2005067498A3 (en) Bioreactor systems and disposable bioreactor
WO2009034927A1 (ja) 細胞培養器具及びこれを用いた細胞培養方法
MXPA03005548A (es) Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
DE502005002929D1 (de) Orale darreichungsform enthaltend probiotische bakterien
WO2004098634A3 (en) Protein arginine n-methyltransferase 2 (prmt-2)
BR0114199A (pt) Sequências de nucleotìdeos que medeiam a fertilidade masculina e métodos de uso das mesmas
ATE549041T1 (de) Bakterienbindendes wischtuch
BRPI0416710A (pt) composição e método para inibir o crescimento de microorganismos em fibras não-celulósicas, fibras não-celulósicas e uso da composição para inibir o crescimento de microorganismos em fibras não-celulósicas
CL2004000979A1 (es) Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida.
AR058185A1 (es) Reactivo para sensores de prueba que contiene polimeros de celulosa
RS51896B (en) The use of glucose isomerase in the treatment of fructose intolerance
BRPI0409326A (pt) método para identificação e obtenção de ácidos nucléicos capazes de modificar a toleráncia ao estresse em plantas
UY29163A1 (es) Derivados de piridina, su preparación y su aplicación en terapéutica
AR023873A1 (es) Formulacion
AR046843A1 (es) Carboxamidas sililadas